The MHRA is working closely with DHSC and other healthcare partners on COVID-19.

We are prioritising work including:

  • Supporting and authorising the development of vaccines
  • Clinical trials of new medicines
  • Managing the supply of medicines and healthcare products

We also provide information to patients, manufacturers and healthcare professionals through our established information channels and alert systems.

The National Institute for Biological Standards and Control (NIBSC), part of the MHRA, also plays a major role in assuring the quality of biological medicines, worldwide.

The MHRA Inspectorate blog has several posts covering the approach taken on clinical trials and advice on other areas like remote working.

Managing clinical trials during Coronavirus (COVID-19)

Clinical trials applications for Coronavirus (COVID-19)


Posted on the UK MHRA website on 23 March 2020